skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 26,355  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Is COVID‐19 infection more severe in kidney transplant recipients?
Material Type:
Article
Add to My Research

Is COVID‐19 infection more severe in kidney transplant recipients?

American Journal of Transplantation, 2021-03, Vol.21 (3), p.1295-1303 [Peer Reviewed Journal]

2020 The American Society of Transplantation and the American Society of Transplant Surgeons ;2020 The American Society of Transplantation and the American Society of Transplant Surgeons. ;2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://novel-coronavirus.onlinelibrary.wiley.com ;2021 The American Society of Transplantation and the American Society of Transplant Surgeons ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1600-6135 ;EISSN: 1600-6143 ;DOI: 10.1111/ajt.16424 ;PMID: 33259686

Digital Resources/Online E-Resources

2
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Material Type:
Article
Add to My Research

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

The New England journal of medicine, 2013-08, Vol.369 (8), p.699-710 [Peer Reviewed Journal]

Copyright © 2013 Massachusetts Medical Society. All rights reserved. ;2014 INIST-CNRS ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1215734 ;PMID: 23964932 ;CODEN: NEJMAG

Full text available

3
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
Material Type:
Article
Add to My Research

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

The New England journal of medicine, 2013-08, Vol.369 (8), p.711-721 [Peer Reviewed Journal]

Copyright © 2013 Massachusetts Medical Society. All rights reserved. ;2014 INIST-CNRS ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1215739 ;PMID: 23964933 ;CODEN: NEJMAG

Full text available

4
International consensus guidance for management of myasthenia gravis: Executive summary
Material Type:
Article
Add to My Research

International consensus guidance for management of myasthenia gravis: Executive summary

Neurology, 2016-07, Vol.87 (4), p.419-425 [Peer Reviewed Journal]

2016 American Academy of Neurology ;2016 American Academy of Neurology. ;2016 American Academy of Neurology 2016 American Academy of Neurology ;ISSN: 0028-3878 ;EISSN: 1526-632X ;DOI: 10.1212/WNL.0000000000002790 ;PMID: 27358333

Full text available

5
International consensus guidance for management of myasthenia gravis: 2020 update
Material Type:
Article
Add to My Research

International consensus guidance for management of myasthenia gravis: 2020 update

Neurology, 2021-01, Vol.96 (3), p.114-122 [Peer Reviewed Journal]

2020 American Academy of Neurology ;Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2020 American Academy of Neurology ;ISSN: 0028-3878 ;EISSN: 1526-632X ;DOI: 10.1212/WNL.0000000000011124 ;PMID: 33144515

Full text available

6
2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases
Material Type:
Article
Add to My Research

2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases

Annals of the rheumatic diseases, 2023-06, Vol.82 (6), p.742-753 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;2023 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;Attribution ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/ard-2022-223335 ;PMID: 36328476

Full text available

7
Blood neurofilament light chain as a biomarker of MS disease activity and treatment response
Material Type:
Article
Add to My Research

Blood neurofilament light chain as a biomarker of MS disease activity and treatment response

Neurology, 2019-03, Vol.92 (10), p.e1007-e1015 [Peer Reviewed Journal]

2019 American Academy of Neurology ;Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2019 American Academy of Neurology ;ISSN: 0028-3878 ;EISSN: 1526-632X ;DOI: 10.1212/WNL.0000000000007032 ;PMID: 30737333

Full text available

8
Atopic Dermatitis
Material Type:
Article
Add to My Research

Atopic Dermatitis

The New England journal of medicine, 2021-03, Vol.384 (12), p.1136-1143 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMra2023911 ;PMID: 33761208

Full text available

9
International Consensus Guidance Statement on the Management and Treatment of IgG4‐Related Disease
Material Type:
Article
Add to My Research

International Consensus Guidance Statement on the Management and Treatment of IgG4‐Related Disease

Arthritis & rheumatology (Hoboken, N.J.), 2015-07, Vol.67 (7), p.1688-1699 [Peer Reviewed Journal]

2015, American College of Rheumatology ;ISSN: 2326-5191 ;ISSN: 2326-5205 ;EISSN: 2326-5205 ;DOI: 10.1002/art.39132 ;PMID: 25809420

Full text available

10
Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease
Material Type:
Article
Add to My Research

Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease

Cochrane database of systematic reviews, 2009-01 (1), p.CD000067 [Peer Reviewed Journal]

EISSN: 1469-493X ;DOI: 10.1002/14651858.cd000067.pub2 ;PMID: 19160175

Full text available

11
2018 update of the EULAR recommendations for the management of Behçet’s syndrome
Material Type:
Article
Add to My Research

2018 update of the EULAR recommendations for the management of Behçet’s syndrome

Annals of the rheumatic diseases, 2018-06, Vol.77 (6), p.808-818 [Peer Reviewed Journal]

Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;Copyright: 2018 © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2018-213225 ;PMID: 29625968

Full text available

12
Preformed T cell alloimmunity and HLA eplet mismatch to guide immunosuppression minimization with tacrolimus monotherapy in kidney transplantation: Results of the CELLIMIN trial
Material Type:
Article
Add to My Research

Preformed T cell alloimmunity and HLA eplet mismatch to guide immunosuppression minimization with tacrolimus monotherapy in kidney transplantation: Results of the CELLIMIN trial

American journal of transplantation, 2021-08, Vol.21 (8), p.2833-2845 [Peer Reviewed Journal]

2021 The American Society of Transplantation and the American Society of Transplant Surgeons ;2021 The American Society of Transplantation and the American Society of Transplant Surgeons. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1600-6135 ;EISSN: 1600-6143 ;DOI: 10.1111/ajt.16563 ;PMID: 33725408

Full text available

13
Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
Material Type:
Article
Add to My Research

Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial

Lancet neurology, 2020-05, Vol.19 (5), p.402-412 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 1474-4422 ;EISSN: 1474-4465 ;DOI: 10.1016/S1474-4422(20)30078-8 ;PMID: 32333898

Full text available

14
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
Material Type:
Article
Add to My Research

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

Annals of the rheumatic diseases, 2014-03, Vol.73 (3), p.492-509 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Copyright: 2014 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2014 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2013-204573 ;PMID: 24161836 ;CODEN: ARDIAO

Full text available

15
Ulcerative colitis
Material Type:
Article
Add to My Research

Ulcerative colitis

The Lancet (British edition), 2017-04, Vol.389 (10080), p.1756-1770 [Peer Reviewed Journal]

Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Apr 29, 2017 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)32126-2 ;PMID: 27914657

Full text available

16
COVID-19 in Lung Transplant Recipients
Material Type:
Article
Add to My Research

COVID-19 in Lung Transplant Recipients

Transplantation, 2021-01, Vol.105 (1), p.177-186 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0041-1337 ;EISSN: 1534-6080 ;DOI: 10.1097/TP.0000000000003508 ;PMID: 33141808

Digital Resources/Online E-Resources

17
Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort
Material Type:
Article
Add to My Research

Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort

Annals of the rheumatic diseases, 2021-10, Vol.80 (10), p.1306-1311 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2021-220272 ;PMID: 33762264

Full text available

18
Targeting immunometabolism as an anti-inflammatory strategy
Material Type:
Article
Add to My Research

Targeting immunometabolism as an anti-inflammatory strategy

Cell research, 2020-04, Vol.30 (4), p.300-314 [Peer Reviewed Journal]

The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1001-0602 ;EISSN: 1748-7838 ;DOI: 10.1038/s41422-020-0291-z ;PMID: 32132672

Full text available

19
Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia
Material Type:
Article
Add to My Research

Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia

Blood, 2015-08, Vol.126 (8), p.1033-1040 [Peer Reviewed Journal]

2015 American Society of Hematology ;2015 ;ISSN: 0006-4971 ;ISSN: 1528-0020 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2015-04-639831 ;PMID: 26130705

Full text available

20
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies
Material Type:
Article
Add to My Research

Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies

Annals of the rheumatic diseases, 2020-05, Vol.79 (5), p.667-668 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2020 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2020-217424 ;PMID: 32241793

Full text available

Results 1 - 20 of 26,355  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (24,659)

Refine My Results

Creation Date 

From To
  1. Before 1976  (378)
  2. 1976 To 1987  (465)
  3. 1988 To 1999  (4,107)
  4. 2000 To 2012  (12,916)
  5. After 2012  (8,495)
  6. More options open sub menu

Language 

  1. English  (25,159)
  2. Japanese  (3,204)
  3. Spanish  (417)
  4. German  (409)
  5. French  (328)
  6. Portuguese  (216)
  7. Italian  (86)
  8. Polish  (30)
  9. Norwegian  (29)
  10. Russian  (29)
  11. Chinese  (24)
  12. Swedish  (16)
  13. Korean  (15)
  14. Croatian  (15)
  15. Turkish  (9)
  16. Serbian  (6)
  17. Czech  (5)
  18. BokmÃ¥l, Norwegian  (2)
  19. Icelandic  (2)
  20. Catalan  (1)
  21. More options open sub menu

Searching Remote Databases, Please Wait